COURT-RULING ·Filed Mar 30, 2026
Actionable Insight • Neutral
Monitor for future docket updates and actual court opinions; these filings suggest potential shareholder litigation risk, but without content, the merits or exposure cannot be assessed.
GERN drugs
GERN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$1.41
T+0 close · Mar 30, 2026 · via day close
Latest settled
−2.84%
T+60 · $1.37
Vs SPY
−19.33%
α at T+60
Horizons
All settled
through T+60
- T+0 · Mar 30 $1.41entry
- T+1 · 8mo ago +5.67%α +2.78% · $1.49
- T+5 · 7mo ago +23.40%α +19.10% · $1.74
- T+20 · 7mo ago +7.09%α −5.50% · $1.51
- T+60 · 5mo ago −2.84%α −19.33% · $1.37
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable
Court Ruling Details
Court
United States District Court for the Northern District of California
Court Level
District
Case Type
securities fraud
Ruling Type
other
Outcome
PARTIAL: mixed ruling, some claims won/lost
Precedent Risk
LOW
Key Facts
- Three derivative and securities-related lawsuits were filed against Geron Corporation in the U.S. District Court for the Northern District of California on March 30, 2026.
- Case numbers: 3:25-cv-08575 (Hyung v. Geron), 3:25-cv-03356 (In re Geron Corporation Derivative Litigation), and 3:25-cv-02563 (Potvin v. Geron).
- No substantive ruling text is available, only PACER login redirects are present in the documents.
Financial Impact
Unknown, no financial terms or damages disclosed
Risk Factors
- Potential for material shareholder litigation if allegations involve undisclosed adverse events or misleading disclosures
- Risk of increased legal expenses and management distraction if cases proceed
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 3 court opinions.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-35h6ngfo-GERN |
| COURT-RULING Data (Synthetic) | court-hharbx1z-GERN |
| COURT-RULING Data (Synthetic) | court-21dsdcox-GERN |
Track record
11 reports on GERN
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $0.9742 Now $0.9400 −3.51% settles Nov 17
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $0.9965 to $0.9419 Now $0.9400 −5.67% ▼ −5.48% −3.79% vs SPY
- Nov 4, 202612d ago 8-K Mixed 6/10 No price data
- Nov 4, 202612d ago Press Release Mixed 6/10 Entry $1.08 to $1.02 Now $0.9400 −12.96% ▼ −5.56% −4.64% vs SPY
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $0.9462 to $0.9501 Now $0.9400 +0.66% ▼ −0.41% −5.14% vs SPY
- Oct 19, 202628d ago Press Release Neutral 2/10 Entry $1.24 to $1.16 Now $0.9400 −24.19% ▼ −6.85% −6.88% vs SPY
- Sep 18, 20268w ago Press Release Neutral 2/10 Entry $1.30 to $1.25 Now $0.9400 −27.69% ▼ −3.85% −2.83% vs SPY
- Apr 22, 202629w ago Press Release Neutral 1/10 Entry $1.55 to $1.52 Now $0.9400 −39.35% ▼ −2.26% −2.31% vs SPY
- Apr 7, 202631w ago DEFA14A Neutral 3/10 Entry $1.71 to $1.69 Now $0.9400 −45.03% ▼ −1.17% −4.69% vs SPY
- Mar 30, 202633w ago Court Ruling Neutral 2/10 Viewing Entry $1.41 to $1.74 Now $0.9400 −33.33% ▲ +23.40% +19.10% vs SPY
Showing 10 of 11
US Market Status
Market Closed · Opens in 6h 13m
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers